Literature DB >> 7403935

Small bowel tumors: a continuing challenge.

L F Martin, M H Max, J D Richardson, G H Peterson.   

Abstract

Small bowel tumors are difficult to diagnose and are frequently not identified at initial evaluation. We retrospectively reviewed 25 consecutive cases to assess the efficacy of procedures currently used in diagnosis. Barium contrast studies were diagnostic in 14 (56%) of the cases. Enteroclysis provided one diagnosis after the initial barium study was negative. Of the 11 patients for whom barium studies were negative, angiography provided the diagnosis in six (three benign, three malignant). Endoscopy was never helpful. Laparotomy was required in five cases (three benign, two malignant) after repeated negative work-ups. An evaluation protocol which calls for each method as needed seems to provide the most reliable means of diagnosing small bowel tumors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7403935     DOI: 10.1097/00007611-198008000-00010

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Jejunal tubulovillous adenocarcinoma in adenoma presenting with entero-enteric intussusception.

Authors:  Nobuhiro Takeuchi; Shuho Semba; Kazuyoshi Naba; Ryota Aoki; Yu Nishida; Yusuke Nomura; Tetsuo Maeda; Hidetoshi Tada
Journal:  Clin J Gastroenterol       Date:  2013-01-12

2.  Two way push videoenteroscopy in investigation of small bowel disease.

Authors:  Y Bouhnik; A Bitoun; B Coffin; R Moussaoui; A Oudghiri; J C Rambaud
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

3.  Diagnostic and therapeutic push type enteroscopy in clinical use.

Authors:  G R Davies; M J Benson; D J Gertner; R M Van Someren; D S Rampton; C P Swain
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Small bowel tumours: yield of enteroscopy.

Authors:  B S Lewis; A Kornbluth; J D Waye
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.